{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    10,
    11,
    23,
    28,
    30,
    38,
    41,
    44,
    47,
    48,
    49,
    51,
    53
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "Appendix A Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.1",
        "sectionTitle": "Appendix A Clinical Laboratory Evaluations",
        "description": "Correction in clinical chemistry panel (removal of Iron) and list of analytes."
      },
      {
        "id": "ref_2",
        "name": "Appendix J Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.10",
        "sectionTitle": "Appendix J Country Specific Requirement - Home Infusions with BIVV009",
        "description": "Reference to home infusion inclusion/exclusion criteria and procedures for specific countries."
      },
      {
        "id": "ref_3",
        "name": "Appendix I Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.9",
        "sectionTitle": "Appendix I Vaccine Schedule for Patients in Japan Only",
        "description": "Specific vaccination schedule for Japanese patients."
      },
      {
        "id": "ref_4",
        "name": "Concomitant Medications Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.2.6",
        "sectionTitle": "Excluded Concomitant Medications",
        "description": "List of allowed and excluded medications during the study."
      },
      {
        "id": "ref_5",
        "name": "Transfusion Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Table 1",
        "sectionTitle": "Transfusion criteria",
        "description": "Criteria for patient transfusion during Part B."
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "The name and numbering of the protocol is based on a new numbering system followed by the Sponsor.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Document History",
        "pageNumber": 2
      },
      {
        "id": "annot_2",
        "text": "Any patient withdrawing from the study after Week 5 and prior to the Week 23 visit will be considered a non-responder.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Responder definition (Table 2)",
        "pageNumber": 31
      },
      {
        "id": "annot_3",
        "text": "Footnote I: Qualifying patients at participating sites may have study drug dosed at home during certain visits in Part B.",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Study Procedures",
        "pageNumber": 5
      },
      {
        "id": "annot_4",
        "text": "Footnote c: Revaccination with booster doses should be given according to regional guidelines for patients with persistent complement deficiency.",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table 3 - Study schedule of events",
        "pageNumber": 42
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "06",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2019-12-19",
        "description": "Amended Clinical Trial Protocol 06 - Global",
        "amendmentNumber": "6"
      },
      {
        "id": "ver_2",
        "versionNumber": "5.0",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-07-17",
        "description": "Clinical Study Protocol Version 5 - Global",
        "amendmentNumber": "5"
      },
      {
        "id": "ver_3",
        "versionNumber": "1.0",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2017-08-24",
        "description": "Original Clinical Study Protocol - Global",
        "amendmentNumber": "0"
      }
    ],
    "summary": {
      "referenceCount": 5,
      "annotationCount": 4,
      "versionCount": 3
    }
  }
}